What does CUSIP 55234L105 represent in this 13F holders report?

CUSIP 55234L105 is the security identifier for LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

How many institutions held LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value in Q2 2024?

49 institutional investors reported LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value for Q2 2024. Use the holders table for investor-level position and value details.

Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

CUSIP: 55234L105

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, $0.001 par value
Shares outstanding: 1,644,695
Total 13F shares: 32,730,111
Share change: -12,858,971
Total reported value: $9,057,490
Put/Call ratio: 0.19%
Reported price per share: $0.28
Number of holders: 49
Value change: -$110,888,174
Number of buys: 26
Number of sells: 54

Security key

55234L105

Report period

Q2 2024

Institutions

Top holders

LYRA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2024 Previous quarter: Q1 2024 Lyra Therapeutics, Inc. SEC filings Lyra Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 55234L105

Newer quarter: Q3 2024 Previous quarter: Q1 2024

Recent filing periods:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Ownership snapshot

Top reported holders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

PERCEPTIVE ADVISORS LLC

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2024

13F Lead comparable stake: 776% Showing 1-6 of 15 holder rows.

Rank 1 holder

PERCEPTIVE ADVISORS LLC

13F

Ownership: 776%
Position: $79.35M

13F

Rank 2 holder

CITADEL ADVISORS LLC

13F

Ownership: 264%
Position: $26.99M

13F

Rank 3 holder

Nantahala Capital Management, LLC

13F

Ownership: 172%
Position: $17.55M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PERCEPTIVE ADVISORS LLC	13F Company 13F	776%	$79,352,035 12,757,562 shares	—	31 Mar 2024
CITADEL ADVISORS LLC	13F Company 13F	264%	$26,989,209 4,339,101 shares	—	31 Mar 2024
Nantahala Capital Management, LLC	13F Company 13F	172%	$17,546,508 2,820,982 shares	—	31 Mar 2024
Samsara BioCapital, LLC	13F Company 13F	169%	$17,293,223 2,780,261 shares	—	31 Mar 2024
Point72 Asset Management, L.P.	13F Company 13F	167%	$17,058,101 2,742,460 shares	—	31 Mar 2024
Venrock Adviser, LLC	13F Company 13F	157%	$16,023,298 2,576,093 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

32,730,111

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

-28

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend